Angelini
Template:Short description Script error: No such module "For".
Page Module:Infobox/styles.css has no content.Page Template:Infobox company/styles.css has no content.
| Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found. | |
Company type | Private |
|---|---|
| ISIN | Script error: No such module "WikidataIB". |
| Industry | Script error: No such module "WikidataIB". |
| Predecessor | Script error: No such module "WikidataIB". |
| Incorporated | Script error: No such module "WikidataIB". |
| Founded | Script error: No such module "WikidataIB". |
| Founder | Script error: No such module "WikidataIB". |
| Defunct | Script error: No such module "WikidataIB". |
| Successor | Script error: No such module "WikidataIB". |
| Headquarters | Rome, Italy |
Area served | Worldwide |
Key people | Franco Masera (Chairman)[1] Sergio Marullo di Condojanni (CEO) |
| Revenue | Script error: No such module "WikidataIB". |
| Script error: No such module "WikidataIB". | |
| Script error: No such module "WikidataIB". | |
| Total assets | Script error: No such module "WikidataIB". |
Number of employees | Script error: No such module "WikidataIB". |
| Parent | Script error: No such module "WikidataIB". |
| Website | www.angeliniindustries.com |
Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".
Angelini is a large, privately owned, Italian industrial group operating internationally. Founded in Italy in the early twentieth century, the Angelini group has offices in 21 countries. Owned by Angelini family and currently led by Sergio Marullo di Condojanni and Thea Paola Angelini, the industrial group employs approximately 5800 people.[3]
History
The antidepressant medication Trazodone was developed in the 1960s by scientists at Angelini.[4]
Since 2000, Angelini has been the producer of Amuchina, the sanitizing solution invented by Oronzio De Nora.[5]
In a 2018, evaluation of firms' reputation issued by Reputation Institute, Angelini ranked 66th in general and second among life sciences companies.[6]
In 2020, Angelini took over ownership of Thermacare after Pfizer spun off the transdermal analgesic patch after its merger with GlaxoSmithKline's consumer healthcare division.
In January 2021, the Swiss biotech company Arvelle Therapeutics was acquired for $960 million.[7]
In 2022 the Angelini has been rebranded as "Angelini Industries". The new brand has been adopted by Angelini Pharma, Angelini Technologies, Angelini Wines & Estates, Angelini Beauty and Angelini Ventures.[8]
References
Page Template:Reflist/styles.css has no content.
- ^ Page Module:Citation/CS1/styles.css has no content."Governance". angeliniindustries.com. Retrieved 2023-03-09.
- ^ a b Page Module:Citation/CS1/styles.css has no content."Angelini Industries: turnover exceeded 2 billion in 2022, it is the first time". 15 June 2023. Retrieved 5 April 2024.
- ^ Who We Are - Angelini
- ^ Page Module:Citation/CS1/styles.css has no content.Gorecki, Dennis K.J.; Verbeeck, Roger K. (1987). "Trazondone Hydrochloride". In Forey, Klaus (ed.). Profiles of Drug Substances, Excipients and Related Methodology Vol. 16. Academic Press. p. 695. ISBN 9780080861111.
- ^ Page Module:Citation/CS1/styles.css has no content."Storia dell'Amuchina, l'igienizzante nato al Sud". www.dottnet.it. Retrieved 2024-10-15.
- ^ https://www.aboutpharma.com/blog/2018/04/19/reputazione-aziendale-ecco-le-migliori-150-societa-in-italia-il-pharma-arranca/ Redazione Aboutpharma Online. 19 April 2018. Retrieved 7 May 2018. Template:In lang
- ^ Page Module:Citation/CS1/styles.css has no content."Italy's Angelini to buy Swiss biotech group for $1bn". Financial Times. 2021-01-03. Retrieved 2022-07-25.
- ^ Page Module:Citation/CS1/styles.css has no content."The Angelini Group becomes "Angelini Industries" and its first corporate advertising campaign kicks off". www.angeliniindustries.com. Retrieved 2024-04-05.
External links
Page Module:Side box/styles.css has no content.Page Template:Sister project/styles.css has no content.